Larimar Therapeutics, Inc.
LRMR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $90 | $21 | $21 | $33 |
| Short-Term Investments | $85 | $118 | $136 | $150 |
| Receivables | $0 | $1 | $1 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $8 | $6 | $7 | $11 |
| Total Curr. Assets | $183 | $146 | $165 | $195 |
| Property Plant & Equip (Net) | $3 | $3 | $4 | $4 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $1 | $1 |
| Total NC Assets | $4 | $4 | $5 | $5 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $187 | $150 | $170 | $200 |
| Liabilities | – | – | – | – |
| Payables | $11 | $4 | $2 | $2 |
| Short-Term Debt | $1 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $33 | $21 | $19 | $21 |
| Total Curr. Liab. | $45 | $27 | $22 | $24 |
| LT Debt | $3 | $3 | $4 | $4 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $3 | $3 | $4 | $4 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $4 | $5 | $5 | $5 |
| Total Liabilities | $48 | $30 | $26 | $28 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$372 | -$325 | -$298 | -$269 |
| AOCI | $0 | -$0 | $0 | $0 |
| Other Equity | $511 | $444 | $443 | $441 |
| Total Equity | $139 | $120 | $144 | $172 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $187 | $150 | $170 | $200 |
| Net Debt | -$86 | -$16 | -$16 | -$28 |